Future considerations for dendritic cell immunotherapy against chronic viral infections.

about

Metabonomic window into hepatitis B virus-related hepatic diseases

P2860

Q26771253-3AD378F0-36EB-4735-B06D-37C5B155B8CA

P2860

Future considerations for dendritic cell immunotherapy against chronic viral infections.

Item

http://www.wikidata.org/entity/Q38204769

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Future considerations for dendritic cell immunotherapy against chronic viral infections.

@en

type

Item

label

Future considerations for dendritic cell immunotherapy against chronic viral infections.

@en

prefLabel

Future considerations for dendritic cell immunotherapy against chronic viral infections.

@en

P1476

Future considerations for dendritic cell immunotherapy against chronic viral infections.

@en

P2093

Ethel Atanley

http://www.w3.org/2001/XMLSchema#string

Sylvia van Drunen Littel-van den Hurk

http://www.w3.org/2001/XMLSchema#string

P2860

Generation of immune responses against hepatitis C virus by dendritic cells containing NS5 protein-coated microparticles

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes

Analysis of successful immune responses in persons infected with hepatitis C virus

Blood monocytes consist of two principal subsets with distinct migratory properties

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer.

Influence of dendritic cells on viral pathogenicity

HIV-1 infection of DC: evidence for the acquisition of virus particles from infected T cells by antigen uptake mechanism.

A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy

Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand.

P304

801-813

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/1744666X.2014.907742

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24734867

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

Future considerations for dendritic cell immunotherapy against chronic viral infections.

about

P2860

P2860

Future considerations for dendritic cell immunotherapy against chronic viral infections.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921